Evidence map›Paper›PMID 28710255›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2017

Cathelicidins Inhibit

Maarten Coorens, Viktoria A F Schneider, A Marit de Groot, Albert van Dijk, Marjolein Meijerink, Jerry M Wells, Maaike R Scheenstra, Edwin J A Veldhuizen, Henk P Haagsman

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 94 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Antimicrobial Peptide CATH-2 Attenuates Avian PathogenicInternational journal of molecular sciences · 2024
    Article
  9. Article
  10. Article
  11. Life science alliance · 2024
    Article
  12. Article
  13. CATH-2-derived antimicrobial peptide inhibits multidrug-resistantFrontiers in cellular and infection microbiology · 2024
    Article
  14. Effects ofPharmaceuticals (Basel, Switzerland) · 2023
    Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Maarten CoorensDivision of Molecular Host Defence, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, 3584 CL Utrecht, the Netherlands.
Viktoria A F SchneiderDivision of Molecular Host Defence, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, 3584 CL Utrecht, the Netherlands.
A Marit de GrootDivision of Immunology, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, 3584 CL Utrecht, the Netherlands; and.ORCID 0000-0002-4782-3392
Albert van DijkDivision of Molecular Host Defence, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, 3584 CL Utrecht, the Netherlands.ORCID 0000-0002-8664-3730
Marjolein MeijerinkHost Microbe Interactomics Group, Department of Animal Sciences, Wageningen University, 6700 AH Wageningen, the Netherlands.
Jerry M WellsHost Microbe Interactomics Group, Department of Animal Sciences, Wageningen University, 6700 AH Wageningen, the Netherlands.
Maaike R ScheenstraDivision of Molecular Host Defence, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, 3584 CL Utrecht, the Netherlands.
Edwin J A VeldhuizenDivision of Molecular Host Defence, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, 3584 CL Utrecht, the Netherlands.ORCID 0000-0002-9133-7965
Henk P HaagsmanDivision of Molecular Host Defence, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, 3584 CL Utrecht, the Netherlands; H.P.Haagsman@uu.nl.ORCID 0000-0002-4931-5201
Utrecht University · NLWageningen University & Research · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Activation of the immune system needs to be tightly regulated to provide protection against infections and, at the same time, to prevent excessive inflammation to limit collateral damage to the host. This tight regulation includes regulating the activation of TLRs, which are key players in the recognition of invading microbes. A group of short cationic antimicrobial peptides, called cathelicidins, have previously been shown to modulate TLR activation by synthetic or purified TLR ligands and may play an important role in the regulation of inflammation during infections. However, little is known about how these cathelicidins affect TLR activation in the context of complete and viable bacteria. In this article, we show that chicken cathelicidin-2 kills

Indexed as

Macrophage ActivationMicrobial ViabilityAnimalsAntimicrobial Cationic PeptidesBlood ProteinsCathelicidinsChickensDogsEscherichia coliGram-Negative BacteriaHumansInflammationMiceProtein PrecursorsSwineToll-Like Receptor 2Antimicrobial Cationic PeptidesBlood Proteinscathelicidin 2 protein, mammalCathelicidinsCMAP27 protein, chickenProtein PrecursorsToll-Like Receptor 2Toll-Like Receptor 4

Identifiers

PMID28710255
PMCPMC5544931
OpenAlexW2734562592

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.